FdaApplication
ANDA 202001
Identifiers
- fda_app_no: ANDA202001
Properties
| Property | Value |
|---|---|
| applicant_name | TORRENT PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2013-02-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | 850MG;EQ 15MG BASE | TABLET;ORAL |
| PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | 500MG;EQ 15MG BASE | TABLET;ORAL |
2 products